Human immunoglobulin (Wuhan Institute of Biological Products)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman immunoglobulin (Wuhan Institute of Biological Products)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionImmunoglobulin agonists
TargetsImmunoglobulin
Therapy Area/IndicationsAgammaglobulinemia
Global Approved IndicationsAgammaglobulinemia
Approved Indications in ChinaAgammaglobulinemia
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWuhan Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsAgammaglobulinemia
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA02
Related LinksN/A